120 related articles for article (PubMed ID: 15678496)
1. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.
Neuhausen SL; Slattery ML; Garner CP; Ding YC; Hoffman M; Brothman AR
Prostate; 2005 Jul; 64(2):168-74. PubMed ID: 15678496
[TBL] [Abstract][Full Text] [Related]
2. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
3. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.
Saracevic A; Nikolac N; Reljic A; Simundic AM
Genet Test Mol Biomarkers; 2011 Mar; 15(3):127-31. PubMed ID: 21204696
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance-related genes and advanced left-sided colorectal adenoma.
Gunter MJ; Hayes RB; Chatterjee N; Yeager M; Welch R; Schoen RE; Yakochi L; Schatzkin A; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):703-8. PubMed ID: 17416760
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
9. Energy balance, insulin-related genes and risk of colon and rectal cancer.
Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W
Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
[TBL] [Abstract][Full Text] [Related]
11. No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer.
Li L; Cicek MS; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2462-3. PubMed ID: 16214935
[No Abstract] [Full Text] [Related]
12. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
13. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis.
Alvaro D; Metalli VD; Alpini G; Onori P; Franchitto A; Barbaro B; Glaser SS; Francis H; Cantafora A; Blotta I; Attili AF; Gaudio E
J Hepatol; 2005 Nov; 43(5):875-83. PubMed ID: 16083987
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer.
Lai MT; Chen RH; Tsai FJ; Wan L; Chen WC
Urol Oncol; 2005; 23(4):225-9. PubMed ID: 16018936
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
16. Reduced insulin/IGF-1 signalling and human longevity.
van Heemst D; Beekman M; Mooijaart SP; Heijmans BT; Brandt BW; Zwaan BJ; Slagboom PE; Westendorp RG
Aging Cell; 2005 Apr; 4(2):79-85. PubMed ID: 15771611
[TBL] [Abstract][Full Text] [Related]
17. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
18. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
20. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
